BioMarin Pharmaceutical, Inc. (BMRN)
61.35
-0.86
(-1.38%)
USD |
NASDAQ |
Sep 24, 16:00
61.55
+0.20
(+0.33%)
After-Hours: 05:19
BioMarin Pharmaceutical Gross Profit (Annual) : 2.505B for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.505B |
| December 31, 2024 | 2.216B |
| December 31, 2023 | 1.842B |
| December 31, 2022 | 1.501B |
| December 31, 2021 | 1.314B |
| December 31, 2020 | 1.256B |
| December 31, 2019 | 1.273B |
| December 31, 2018 | 1.152B |
| December 31, 2017 | 1.041B |
| December 31, 2016 | 870.92M |
| December 31, 2015 | 709.37M |
| December 31, 2014 | 615.30M |
| December 31, 2013 | 449.51M |
| December 31, 2012 | 399.86M |
| December 31, 2011 | 326.84M |
| Date | Value |
|---|---|
| December 31, 2010 | 294.89M |
| December 31, 2009 | 255.90M |
| December 31, 2008 | 239.61M |
| December 31, 2007 | 98.85M |
| December 31, 2006 | 63.51M |
| December 31, 2005 | 12.96M |
| December 31, 2004 | 1.409M |
| December 31, 2003 | -9.442M |
| December 31, 2002 | 5.415M |
| December 31, 2001 | 5.526M |
| December 31, 2000 | 5.66M |
| December 31, 1999 | 1.295M |
| December 31, 1998 | 0.5035M |
| December 31, 1997 | -0.0048M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Vertex Pharmaceuticals, Inc. | 10.27B |
| Ascendis Pharma A/S | 691.49M |
| BridgeBio Pharma, Inc. | 478.38M |
| Incyte Corp. | 4.703B |